Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart FailureAlexandre Mebazaa, for the SURVIVE Investigators, Franz X. Kleber et al.|JAMA|2007Cited by 987
Levosimendan vs. Dobutamine: Outcomes for Acute Heart Failure Patients on β-Blockers in SURVIVEAlexandre Mebazaa, Alain Cohen‐Solal, Markku S. Nieminen et al.|European Journal of Heart Failure|2009Cited by 193